Date: June 6, 2024
Time: 8:30-18:00 CEST
Format: Poster presentation: Ex-vivo translational assay of hepatic stellate cells using patient-derived serum characterizes the anti-fibrotic activity of CM-101
Presenter: Revital Aricha, PhD, Vice President, Translational Science, Chemomab Therapeutics
Session: Poster - Fibrosis/Stellate cell biology, Abstract #380

Date: June 6, 2024
Time: 8:30-17:00 CEST
Format: Poster presentation: Machine learning-driven identification of serum protein signature for primary sclerosing cholangitis and enhanced liver fibrosis score
Presenter: Ilan Vaknin, PhD, Vice President, R&D, Chemomab Therapeutics
Session: Immune-mediated and cholestatic: Experimental and pathophysiology, Abstract #1032

Date: June 7, 2024
Time: 12:25-13:45 CEST
Format:  Poster Tour: Ex-vivo translational assay of hepatic stellate cells using patient-derived serum characterizes the anti-fibrotic activity of CM-101
Presenter: Ilan Vaknin, PhD, Vice President, R&D, Chemomab Therapeutics
Session: Fibrosis/Stellate Cell Biology Poster Tour, Abstract #380
Location: Basic Science Track Hub
Information: EASL Congress 2024